Next Article in Journal
2,3-Dimethoxycinnamic Acid from a Marine Actinomycete, a Promising Quorum Sensing Inhibitor in Chromobacterium violaceum
Previous Article in Journal
Ethanol Extract of Limonium bicolor Improves Dextran Sulfate Sodium-Induced Ulcerative Colitis by Alleviating Inflammation and Restoring Gut Microbiota Dysbiosis in Mice
Previous Article in Special Issue
Tissue Distribution and Metabolization of Ciguatoxins in an Herbivorous Fish following Experimental Dietary Exposure to Gambierdiscus polynesiensis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 22
Issue 4
10.3390/md22040176
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Automated Patch Clamp for the Detection of Tetrodotoxin in Pufferfish Samples

by
Mònica Campàs
1,*,
Jaume Reverté
1,2,
Àngels Tudó
2,
Mounira Alkassar
1,2,
Jorge Diogène
1 and
Francesc X. Sureda
2,*
1
IRTA, Marine and Continental Waters (AMiC) Programme, Ctra. Poble Nou del Delta, km. 5.5, 43540 La Ràpita, Spain
2
Department of Basic Medical Sciences, Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, Spain
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2024, 22(4), 176; https://doi.org/10.3390/md22040176
Submission received: 22 March 2024 / Revised: 10 April 2024 / Accepted: 12 April 2024 / Published: 15 April 2024
(This article belongs to the Special Issue Marine Biotoxins 3.0)
Browse Figures
Versions Notes

Abstract

:
Tetrodotoxin (TTX) is a marine toxin responsible for many intoxications around the world. Its presence in some pufferfish species and, as recently reported, in shellfish, poses a serious health concern. Although TTX is not routinely monitored, there is a need for fast, sensitive, reliable, and simple methods for its detection and quantification. In this work, we describe the use of an automated patch clamp (APC) system with Neuro-2a cells for the determination of TTX contents in pufferfish samples. The cells showed an IC50 of 6.4 nM for TTX and were not affected by the presence of muscle, skin, liver, and gonad tissues of a Sphoeroides pachygaster specimen (TTX-free) when analysed at 10 mg/mL. The LOD achieved with this technique was 0.05 mg TTX equiv./kg, which is far below the Japanese regulatory limit of 2 mg TTX equiv./kg. The APC system was applied to the analysis of extracts of a Lagocephalus sceleratus specimen, showing TTX contents that followed the trend of gonads > liver > skin > muscle. The APC system, providing an in vitro toxicological approach, offers the advantages of being sensitive, rapid, and reliable for the detection of TTX-like compounds in seafood.

Graphical Abstract

1. Introduction

Marine toxins are a broad group of compounds that may be present in fish, shellfish, and other marine organisms and accumulate throughout food webs, putting consumers at risk. These toxins are byproducts of the metabolism of several microorganisms like microalgae and bacteria and have different mechanisms of action. One of the most toxic marine toxins is tetrodotoxin (TTX), which is thought to be produced by several bacteria species [1,2]. Tetrodotoxin is a water-soluble molecule with a low molecular weight (319.27 g/mol), consisting of guanidinium moiety connected to a highly oxygenated carbon backbone with a 2,4-dioxaadamantane portion containing five hydroxyl groups [3]. Up to now, more than 30 TTX analogues have been described. Tetrodotoxins are usually found in pufferfish (from the family Tetraodontidae), although their presence has also been reported in other marine species and terrestrial animals, such as gastropods, newts, crabs, frogs, sea slugs, starfishes, blue-ringed octopuses, and ribbon worms [4,5,6]. This toxin is responsible for thousands of intoxications every year in Japan and China, where fugu, a delicacy fish only served in selected restaurants, is consumed. However, intoxication cases have also been described in other countries [7]. For instance, the 37th Annual Report of the American Association of Poison Control Centers’ reported 210 cases of TTX poisoning in the USA [8]. In Europe, only one case has been registered after the ingestion of shellfish (Charonia lampas lampas) [9,10] in Spain. Nevertheless, in the Mediterranean Sea, where 13 species of pufferfish have been reported [11], the presence of toxic pufferfish is increasing in part due to the invasion of Lagocephalus sceleratus through the Suez Canal [12], which was first reported in Turkey in 2003 [13,14].
To avoid intoxications, the Japanese government established a regulatory limit of 2 mg TTX equiv./kg of tissue in pufferfish [15]. In the European Union, fishery products derived from the family Tetraodontidae must not be placed on the market (Regulation (EC) No. 854/2004) [16]. Regarding its presence in shellfish, the CONTAM panel of the European Food Safety Authority (EFSA) concluded that a concentration lower than 44 µg TTX/kg of shellfish meat and/or the equivalent toxic amount of its analogues, based on a portion size of 400 g, is not expected to result in adverse effects in humans [17].
Like for other marine toxins, the mouse bioassay (MBA) was initially implemented for the detection of TTX in food. Due to its low specificity and ethical concerns, other methods have been developed. Instrumental analysis techniques like high-performance liquid chromatography coupled to fluorescence detection (HPLC-FLD) and liquid chromatography coupled to mass spectrometry (LC-MS/MS) attain low limits of detection (LODs) [18]. However, they are subject to limitations like complexity and costs both derived from the required expensive equipment and trained personnel. Availability of standards can also be a critical issue. In these instrumental analysis techniques, the detection is based on the chemical structure of the compounds. On the contrary, cell-based assays (CBAs) are based on the effect of the toxin and its mechanism of action and, therefore, provide an estimation of the toxicity of a sample. Typically, neuroblastoma cell lines have been used to detect toxins of marine origin [19,20]. This is due to the presence in the cells of several targets that are normally affected by marine toxins and that may cause a loss in function or cell death, the endpoint of which is usually measured in many methods [21,22,23]. Among them, Neuro-2a cells are a particular type of neuroblastoma from mice that has been used for TTX detection [24,25]. Tetrodotoxins, acting through the blockade of voltage-gated sodium channels (VGSCs, also known as Nav channels) that are present in Neuro-2a cells, prevent the lethal effect of ouabain and veratridine, two drugs that evoke the continuous depolarisation of these cells through different mechanisms and ultimately their death, which is detected using a colorimetric method [19]. Unfortunately, the CBA also requires trained personnel and is time-consuming, as several days are needed to detect toxicity from a sample. Other analysis methods include immunoassays and aptamer-based assays, as well as immunosensors and aptasensors, based on antibodies and aptamers, respectively, and therefore recognising chemical structure and not toxicity [26,27,28,29,30].
Effect on ion channels is a common feature of some marine toxins [31] and, as mentioned before, TTX and analogues act through the blockade of Nav channels. This mechanism of action has been thoroughly studied using patch clamp electrophysiological assays, where the membrane potential of a cell or a portion of a nerve is controlled, and the ionic currents are recorded. As patch clamp experiments are delicate and require specifically trained personnel, several attempts have been pursued to make electrophysiological experiments more accessible to general laboratory personnel and, most importantly, more efficient in terms of high-throughput analysis. This has been achieved by replacing the patch clamp pipette with a planar glass chip wherein the cell is immobilised, avoiding the use of microscopes and micromanipulators, and providing a complete robotised system, called automated patch clamp (APC). This system has been widely used since the 2000s by the pharmaceutical industry in screening studies for pharmacological activity and in preclinical toxicology. Regarding its application to marine toxins, several groups have explored the use of APC to study the mechanism of action of azaspiracids (AZAs) [32], ciguatoxins (CTXs) [33], and brevetoxins (PbTxs) [34], and to determine toxicity equivalency factors (TEFs) of paralytic shellfish poisoning (PSP) toxins [35]. Although TTX has already been detected in an APC system [36], Neuro-2a cells, which are the gold standard in CBAs, have never been used in APC systems. Furthermore, fish samples containing TTX have never been analysed in APC systems either. In this work, Neuro-2a cells have been used in an APC system and tested for TTX detection. The possible pufferfish matrix effects both on the Nav function and on the blockade by TTX have been evaluated using tissue extracts from a Sphoeroides pachygaster specimen (TTX-free). The APC system was then applied to the determination of TTX contents in tissue extracts from a L. sceleratus specimen (TTX-containing specimen) and the results were compared to those obtained with CBAs, as well as instrumental analysis and immunochemical techniques from a previous work. This is the first attempt to evaluate the applicability of APC with Neuro-2a cells and to detect TTX in naturally contaminated fish samples.

2. Results

2.1. Suitability of Neuro-2a Cells for TTX Detection Using APC

With the aim of verifying the suitability of our Neuro-2a cells for the detection of TTX with APC, the electrophysiology activity of these cells was initially assessed prior to toxin exposure. Once the whole-cell configuration was achieved (with sealings higher than 1 GΩ), the Neuro-2a cells used in this work showed a half-activation potential (Vhalf) of −16 mV and a peak current of −950 pA (Figure 1).
Then, the response of these cells to compounds with VGSC-blocking activity was assessed. First, the blocking activity of lidocaine and tetracaine was evaluated. A dose-dependent reduction in Nav currents was observed by the effect of these two well-known anaesthetics used as drugs for relieving local pain (Figure 2). Lidocaine inhibited Nav currents with an IC50 of 717.2 µM, whereas tetracaine showed a higher blocking activity with an IC50 of 22.5 µM.
Next, the blocking activity of TTX was evaluated. The Nav currents in Neuro-2a cells were completely inhibited when perfusing the system with a solution of TTX at 100 nM. This blockage could be reversed by injecting external solution into the APC chip (system regeneration), indicating that the effect of TTX on the electrophysiological activity of the VGSCs is transient. After regeneration, the response of the Neuro-2a cells to TTX was still the same, allowing for the reuse of the system multiple times as long as the sealing and the membrane integrity remained stable (no leakage currents). From the dose–response curve for TTX, an IC50 value of 6.4 nM was obtained (Figure 3).
The fact that Neuro-2a cells have shown an electrophysiological activity close to other cell types also used in the patch clamp together with the good sensitivity to VGSC blockers suggested their suitability as a cellular model for the analysis of samples potentially containing TTX with APC.

2.2. Evaluation of Pufferfish Matrix Effects on Nav Function and Blockade by TTX

The analysis of compounds of interest in biological samples can be affected by the presence of components other than the analyte. To study the matrix effects in Nav currents from Neuro-2a cells, we evaluated the effect of different dilutions of tissue extracts (muscle, skin, liver, and gonads) from a S. pachygaster pufferfish specimen on the system with immobilised Neuro-2a cells. The extracts were previously tested for the presence of TTX by LC-MS/MS and were considered negative [37], as well as by CBAs. Experiments showed that the Nav currents start to decrease at the highest matrix concentration (1:10 dilution) for skin and gonads, whereas for muscle and liver, the VGSC activity remained stable (Figure 4). Nevertheless, this inhibition of the signal was never higher than 20%, since VGSC activity was always higher than 80%, which is the value used as a threshold in the quantification of TTX contents. For good measure, the 1:20 dilution (10 mg/mL) was chosen as a safe tissue extract dilution to work with in subsequent experiments.
Even though the tissue is used at a concentration that does not interfere with the Nav current recordings in Neuro-2a cells, we cannot exclude that matrix compounds do not interfere on the blockade action of VGSCs by TTX. Therefore, to evaluate this potential interference, pufferfish tissue extracts (at 1:20 dilution) of the S. pachygaster specimen (TTX-free) were spiked with serial concentrations of TTX. Each dose–response curve was fitted to a sigmoidal four-parameter logistic curve (Figure 5), and analytical parameters were obtained. In Table 1, the Hill slope (slope of the sigmoidal curve between the two plateaus), IC50 (half-maximal inhibitory concentration), and R2 (coefficient of determination) values of the five equations are detailed. No significant differences among Hill slopes or among IC50 values from the dose–response curves for the five groups (buffer and four tissues) were obtained (p value > 0.05). Therefore, the data revealed that, at this matrix concentration, the compounds from the tissues of S. pachygaster used as a TTX-free specimen do not interfere with the TTX calibration curve and proved that the assay could be applied to the analysis of TTX in pufferfish samples. Additionally, recovery being 100%, there is no need to apply any recovery factor in the determination of TTX contents.
The cells used in the APC system showed a working range of 0.05–1.00 mg TTX equiv./kg (between IC20 and IC80). The repeatability and intermediate precision at 0.15, 0.30, and 0.60 mg TTX equiv./kg were evaluated by performing multiple measurements on the same day and different days, respectively. The relative standard deviation (RSD) values for the measurements performed on the same day were 14, 11 and 10% (N = 4) for 0.15, 0.30, and 0.60 mg TTX equiv./kg, respectively. The RSD values for the measurements performed on different days were 12, 9, and 5% (N = 4) for 0.15, 0.30, and 0.60 mg TTX equiv./kg, respectively. According to AOAC, the system showed appropriate reliability, as the Horwitz ratio (HorRat) values (ratio of the RSD calculated from the data to the RSD predicted from the Horwitz equation, which is 11% when the analyte concentration is 1 ppm) were between 0.5 and 1.3 (and are considered acceptable between 0.5 and 2) [38,39].

2.3. Analysis of TTX in Lagocephalus Sceleratus Samples

The APC system with Neuro-2a cells was then used to quantify the TTX contents in different tissues of a L. sceleratus pufferfish specimen (Table 2). Additionally, extracts were analysed by a CBA recently developed by our group [25]. The extracts had also been analysed by several techniques in previous works: LC-MS/MS, liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS), maleimide-based enzyme-linked immunosorbent assay (mELISA) [37], electrochemical immunosensor, and optical surface plasmon resonance (SPR) immunosensor [40].
The APC system revealed the presence of TTX equiv. in all extracts, with contents above the Japanese regulatory limit of 2 mg TTX equiv./kg for all tissues except for muscle. Gonads was the most toxic tissue, followed by liver, skin, and muscle. The TTX levels in these tissues were also determined using the CBA and the results followed the same trend as that provided by the APC: gonads > liver > skin > muscle.

3. Discussion

The use of primary cell cultures freshly initiated from animal tissues for electrophysiology studies using patch clamp has been widely explored in the literature [41,42]. Due to their origin, the distribution of VGSCs on the membranes of these cells is highly conserved, and this is interesting from an analytical point of view since they may provide toxicological responses closely related to the ones suffered in real poisoning events. However, the difficulties associated with cell culturing added to the dependence on animals as a source of cells from primary cultures reduce their applicability [23], especially when high throughput analysis is pursued and high cellular densities are required. Contrarily to primary cell cultures, immortalised cell lines may not express all receptors present in vivo. Nonetheless, cancer cell lines are certainly excellent models when the target receptors fit the purpose of a specific research [43]. In recent decades, there has been a tendency towards the use of immortalised cell lines for patch clamp due to their simplicity in terms of handling and their high growth rate. At the physiological level, not all the VGSC subtypes are sensitive to TTX. In fact, from the nine closely related VGSCs known in mammals, only Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, and Nav1.7 are sensitive to TTX, whereas Nav1.5, Nav1.8, and Nav1.9 are resistant [44,45]. Additionally, among the TTX-sensitive VGSCs, there are differences regarding the affinity to TTX. Nav1.3 is one of the VGSCs with more affinity against TTX [46]. However, not much is known about the affinity of VGSCs against other TTX analogues that may also be present in naturally contaminated samples. For example, Nav1.6 has more sensitivity to 4,9-anhydroTTX than Nav1.3 [47]. Due to the still missing information regarding all Nav channels and TTX analogues and because the main objective of this work is to demonstrate that APC is a useful bioanalytical tool for the detection of TTX in pufferfish, the use of a cell line with a heterogenic expression of VGSCs for a global electrophysiology assessment was desired. Therefore, we selected Neuro-2a cells as a cellular model for this study.
Neuro-2a cells are an immortalised murine neuroblastoma cell line widely used for toxicological studies due to their ability to endogenously express VGSCs, the target of several marine neurotoxins. The electrophysiological activity of this cell line has been previously studied in other works [48,49,50,51,52]. However, certain discrepancies have been observed with regard to the activation potential required to depolarise the cell and/or the Nav current intensities achieved. This variability in the electrophysiological activity of Neuro-2a cells may be attributed to the heterogenicity of this type of cell cultures, which may display notorious differences in the expression of VGSCs with respect to the parental cell type [53], or even from one cell batch to another. In this work, Neuro-2a cells showed appropriate Nav currents and a Vhalf of activation similar to that reported for human Nav1.3 [54]. Even though the peak intensity was lower than in other studies with primary cultures from human hippocampus (around −2000 pA) [55], it was higher than that reached in other works with undifferentiated Neuro-2a cells (−285 pA) [56]. Therefore, according to these results, the Neuro-2a cells showed an appropriate electrophysiological activity on APC without the need of any cell differentiation or sensitisation pretreatment. When lidocaine and tetracaine were evaluated, IC50 values were similar to other values already published for cells expressing VGSCs [57,58]. Regarding TTX, complete inhibitions were observed at 100 nM, as also observed with ND7/23 (another murine neuroblastoma cell line) [59], and the IC50 value agreed with those reported with other cellular models only expressing Nav1.1 [47], Nav1.2 [60], Nav1.3 [47], Nav1.4 [61], Nav1.6 [62], or Nav1.7 [63]. Compared to lidocaine and tetracaine, TTX had a VGSC-blocking activity more than 103 and 105-fold higher, respectively.
Automated patch clamp cannot distinguish between the different TTX analogues that may be present in a sample, but it provides an excellent approximation of the overall toxicity of that sample due to the presence of VGSC blockers. Nevertheless, as in any analytical technique, matrix effects should be carefully evaluated. Considering that tissue extracts should be diluted at least 20 times (10 mg/mL) and 20% as the minimum value of detectable blockade using this method, which corresponds to 0.5 ng/mL, our system should be able to detect as low as 0.05 mg TTX equiv./kg in pufferfish samples. This value is far below the Japanese regulatory limit of 2 mg TTX equiv./kg. The application of the APC system with Neuro-2a cells to the analysis of different tissues of a L. sceleratus pufferfish specimen provided the TTX equiv. contents in those samples. The TTX levels quantified in L. sceleratus tissues were in the range of those obtained in other studies: 0.05−58.44, 0.1−35.05, 0.09−1380.8, and 0.17−8248.51 mg TTX equiv./kg in muscle, skin, liver, and gonads, respectively [25]. The high TTX contents in the liver and/or gonads of pufferfish have already been observed in other works [12,25,64,65,66,67,68]. Regarding the high TTX contents found in the liver, Anastasiou and co-workers suggested that it is related to hepatic uptake [66]. As also reported in other studies [69,70,71], TTX is initially accumulated at high concentrations in the liver, then transferred to the skin of males or gonads of females. The L. sceleratus specimen analysed in this work was a female. Many studies on different pufferfish species attribute the high TTX concentrations in gonads to the enhancement of the reproduction success and the role of TTX as a male-attracting pheromone [64,65,68,72].
The CBA previously developed by our group is also based on the effect of TTX on Neuro-2a cells and it also provides a composite toxicological response from a sample. However, the variable used to measure the toxicological effect is different. Whereas in the APC the Nav currents are recorded, in this CBA cell viability is monitored using the MTT dye. As previously mentioned, in the CBA TTX counteracts the toxic effect of ouabain and veratridine (which induce cytotoxicity), resulting in higher cell viability with respect to the controls without TTX. The fact that APC and CBA measure different variables to estimate toxicity may explain that the determined TTX contents are slightly different between these two methods for some tissues; for example, the liver. It is important to note that the liver was the tissue with the highest fat content and that required an additional liquid-liquid partition with hexane for the purification of the extract. Therefore, the effect of liver matrix compounds on the response cannot be completely ruled out. In fact, this tissue is the one that shows the greatest variability among analytical techniques. While the APC and the CBA provide a toxicological response, each one has its own advantages and limitations. In the APC, the VGSC blocking activity is evaluated with non-treated cells. On the contrary, the CBA requires the use of ouabain and veratridine, which represent an additional stress in the cells previous to the exposure to the extracts and more controls. The CBA requires 48 h (24 h for cell immobilisation on plates and 24 h for toxin exposure and cell viability measurement), whereas in the APC, results can be obtained in less than 30 min. On the other hand, the CBA is usually performed on 96-well plates, whereas the chips used in this work contain only eight chambers, which nevertheless is more than in conventional patch clamp. Still, APC systems have already been designed to record up to 384 cells in parallel. Additionally, in the APC system, the TTX blocking activity can be reversed by perfusing the cells with external solution, restoring the sodium currents, and therefore making it possible to regenerate and reuse the system.
When comparing the TTX contents obtained from these two toxicological approaches with the results provided by LC-MS/MS and LC-HRMS, it is important to take into account that these instrumental analysis techniques determine individual TTX and TTX analogue contents based on their chemical structures, not their toxicities. Therefore, the use of TEFs plays a crucial role in translating the TTX analogue data into global toxicity estimations, expressed as TTX equivalents (Table 1). Ideally, when comparing both techniques, TEFs derived from APC should be applied to TTX analogues. However, the relative toxicity of TTX analogues has not been determined by APC yet. In this work, TEFs previously obtained by the CBA [25] have been applied: 0.75, 0.404, 0.139, and 0.011 for 5,11-dideoxyTTX, 11-norTTX-6(S)-ol, 11-deoxyTTX, and 5,6,11-trideoxyTTX, respectively. Additionally, TEFs for 4-epiTTX, 11-norTTX-6(R)-ol, 4,9-anhydro-5,6,11-trideoxyTTX, and 4,4a-anhydro-5,6,11-trideoxyTTX were assumed to be those of their corresponding isomeric analogues. For 4,9-anhydroTTX and 5-deoxyTTX, not investigated in that work, a TEF = 0 was assumed, since trials with MBA resulted in very low toxicities [73,74]. The results obtained by instrumental techniques, after applying the corresponding TEFs, followed the same trend as those provided by APC, gonads being the most toxic tissue followed by liver, skin, and muscle. However, as also observed when comparing with CBAs, a considerable difference was observed in the TTX contents of the liver extract between APC and instrumental analysis methods. The presence of unknown TTX analogues that have not been quantified or liver matrix compounds could be responsible for this discrepancy. On the other hand, it is important to state that both the CBA and the APC provide an estimation of TTX contents resulting from their initial interaction with the VGSCs. Hence, the potential presence in the studied samples of other compounds acting directly on these receptors such as other VGSC blockers or VGSC activators may also interfere with the TTX estimations.
Immunochemical techniques provide a global response from all TTX and TTX analogues that cross-react with the antibody. Again, each TTX analogue cross-reacts with a higher or lower structural affinity, contributing at a higher or lower extent to the global response [23,75]. The TTX contents obtained with the APC were of the same order of magnitude as those provided by the immunochemical approaches. Slight differences between immunosensing and toxicity approaches may be attributed to differences between cross-reactivity and toxicity factors of the present TTX analogues and/or the matrix effects that may interfere in the quantifications obtained with the immunosensing tools.

4. Materials and Methods

4.1. Reagents and Equipment

Tetracaine hydrochloride and lidocaine hydrochloride monohydrate were obtained from Merck KGaA (Darmstadt, Germany). Tetrodotoxin standard was purchased from Tocris Bioscience (Bristol, UK) and the standard solution was prepared at 1 mg/mL in 1% acetic acid. The automated patch clamp Patchliner with 8 amplifier channels, 2 HEKA EPC10 Quadro amplifiers, NPC-16 borosilicate recording chips (medium resistance), external solution (140 mM NaCl, 4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM D-glucose monohydrate, 10 mM HEPES/NaOH, pH 7.4), internal solution (50 mM CsCl, 10 mM NaCl, 60 mM CsF, 20 mM EGTA, 10 mM HEPES/CsOH, pH 7.2), and seal enhancer solution (10 mM HEPES, 130 mM NaCl, 5 mM glucose, 4 mM KCl, 10 mM CaCl2, 1 mM MgCl2, pH 7.4, MOsm 302) were obtained from Nanion Technologies GmbH (Munich, Germany). Neuroblastoma murine (Neuro-2a) cells were purchased from ATCC LGC standards (Manassas, VA, USA). Foetal bovine serum (FBS), penicillin/streptomycin solution, phosphate-buffered saline (PBS), Roswell Park Memorial Institute (RPMI) medium, sodium pyruvate, trypsin-EDTA enzyme, ouabain, veratridine, and thiazolyl blue tetrazolium bromide (MTT) were purchased from Merck KGaA (Darmstadt, Germany).

4.2. Pufferfish Samples and Tetrodotoxin (TTX) Extraction

Fish extracts were obtained from a previous work [54]: one blunthead pufferfish (Sphoeroides pachygaster, Müller and Troschel, 1848) (TTX-free specimen) and one silver-cheeked toadfish (Lagocephalus sceleratus, Gmelin, 1789) (TTX-containing specimen) caught in 2014 in Dénia (Alicante, Spain).
The two pufferfish specimens were dissected, and the muscle, skin, liver, and gonads were retrieved. A double TTX extraction was performed as previously described [76]. Initially, 10 g of pufferfish tissue was weighed in 50 mL tubes and mixed with 25 mL of 0.1% acetic acid. After vortexing for 2 min at 2500 rpm, the tubes were immersed in a water bath set at 100 °C for 10 min with occasional stirring. Then, the tubes were cooled down and centrifuged at 2500 rpm for 5 min at 4 °C. The supernatants were collected, and a second extraction was performed with 20 mL of 0.1% acetic acid. The supernatants from the two extractions were pooled and, for the liver samples, an additional liquid–liquid partition with hexane (1:1) was performed to remove fats. The final volume was set to 50 mL, obtaining extracts at a matrix concentration of 200 mg equiv. of pufferfish tissue/mL. All extracts were kept at −20 °C until required. The pufferfish tissue extracts were analysed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), with an LOD and a limit of quantification (LOQ) of 0.05 mg/kg and 0.1 mg/kg, respectively (Rambla-Alegre et al. 2017 [37]).

4.3. Neuro-2a Cell Line Maintenance

Cells were maintained in RPMI-1640 medium with L-glutamine solution, supplemented with 10% heat-inactivated FBS, penicillin/streptomycin solution at 0.01 mg/mL and 10 U/mL, respectively, and 1 mM sodium pyruvate in an incubator (BINDER GmbH, Tuttlingen, Germany) at 37 °C in 5% CO2 humid atmosphere. The cells used in this work were between the passages 245 and 255.

4.4. Automated Patch Clamp Recording

The electrophysiological changes on Neuro-2a cells were recorded using the Patchliner (Nanion Technologies GmbH, Munich, Germany), an automated planar patch clamp device that allows for the analysis of up to eight individual cells simultaneously. The analysis with the Patchliner process is as follows: first, the wells from an NPC-16 borosilicate chip (medium resistance) (Nanion Technologies GmbH, Munich, Germany) were filled up with the internal and external solutions. After checking the electrode contacts, Neuro-2a cell suspension at 100,000 cells/mL in RPMI-1640 and external solution (1:1 ratio) were injected into the chip. A single cell was immobilised on the hole located at the bottom of the chip at a holding potential of −30 mV. After the addition of the enhancer solution for cell sealing, the potential was changed to −100 mV. Patching was assumed to be successful when observing a stable sealing along time, and resistance around 1 GΩ.
For the calibration curves, tetracaine, lidocaine, and TTX standard solutions at different concentrations (0.1, 1, 3, 10, 30, 100, and 300 μM for tetracaine; 1, 10, 100, 300 µM, and 1 and 3 mM for lidocaine; and 0.1, 1, 3, 10, 30, 100 nM, and 1 μM for TTX) were injected. For the evaluation of pufferfish matrix effects in the absence of TTX, tissue extracts of a S. pachygaster specimen at different dilutions of (1:1000 (0.2 mg/mL), 1:500 (0.4 mg/mL), 1:200 (1 mg/mL), 1:100 (2 mg/mL), 1:20 (10 mg/mL), and 1:10 (20 mg/mL)) were injected. For the evaluation of pufferfish matrix effects in the presence of TTX, tissue extracts of a S. pachygaster specimen at 1:20 dilution (10 mg/mL) were spiked with different TTX concentrations (0.1, 1, 3, 10, 30, 100 nM, and 1 μM) and injected. For the determination of TTX contents in pufferfish samples, tissue extracts of a L. sceleratus specimen at different dilutions were injected. In all cases, a volume of 15 µL was injected at a flow rate of 30 µL/s. Nav currents were measured by applying 10 mV increments from −80 mV to 40 mV for 20 ms using two EPC Quatro USB amplifier units (8 probes) (HEKA Elektronik, Stuttgart, Germany) controlled and digitalised in real time with the Patchmaster software (Nanion Technologies GmbH, Munich, Germany). Measurements were performed in triplicate.

4.5. Colorimetric Cell-Based Assay (CBA)

The colorimetric CBA was performed as in our previous work [25]. Neuro-2a cells were trypsinised and suspended in culture medium (the same as for maintenance but with 5% FBS instead of 10% FBS). Then, Neuro-2a cells were seeded in a 96-well microplate at a density of 35,000 cells/well in 200 µL of culture medium for 24 h at 37 °C in 5% CO2 humid atmosphere. Prior to exposure to TTX standard solution or pufferfish tissue extracts, some Neuro-2a cells were pre-treated with 20 µL of an ouabain and veratridine mixture in PBS at final concentrations of 0.125 and 0.2 mM, respectively. Tetrodotoxin standard solution and pufferfish tissue extracts were dried under an N2 stream at 40 °C using a TurboVap evaporator (Zymark corp., Hopkinton, MA, USA), reconstituted in culture medium and serially diluted, and 10 µL was added to the wells with and without ouabain/veratridine pre-treatment. After 24 h, cell viability was measured using the MTT assay (Manger et al. 1993). Absorbance at 570 nm was measured with a Synergy LX microplate reader from BioTek (Agilent Technologies, Inc., Santa Clara, CA, USA). Measurements were performed in triplicate.

4.6. Statistical Analyses

The dose–response inhibition curve for lidocaine, tetracaine, and TTX were fitted to sigmoidal four-parameter logistic curve models. To evaluate the effect of the tissue (mussel, skin, liver, and gonads) matrix compounds on the blockade caused by TTX, these curves were also fitted to sigmoidal four-parameter logistic curve models, and the Hill slope and IC50 values were estimated. Differences among dose–response curves (in the absence and presence of extract of different tissues from S. pachygaster at 1:20 dilution) were assessed by comparing the Hill slopes and IC50 values of the five groups (buffer and four tissues) using the Kruskal–Wallis test (non-parametric equivalent of the analysis of variance (ANOVA) test), since data were not normally distributed (according to the Shapiro–Wilk test). Differences were considered statistically significant at the p value < 0.05. Statistical analyses were performed using the statistical software Prism 5.0 (GraphPad Software Inc, San Diego, CA, USA).

5. Conclusions

In this work, Neuro-2a cells were used in a whole-cell configuration APC system, showing appropriate electrophysiological activity. When exposed to TTX, an IC50 of 6.4 nM was obtained, similar to those observed with other cells. Regarding the applicability of the APC system to the analysis of pufferfish samples, the presence of muscle, skin, liver, and gonads tissues of a S. pachygaster specimen (TTX-free) at 10 mg/mL did not interfere with the assay and an LOD of 0.05 mg TTX equiv./kg was attained, far below the Japanese regulatory limit. The APC system was applied to the analysis of extracts of a L. sceleratus specimen, showing TTX contents that followed the trend of gonads > liver > skin > muscle, comparable to that obtained with other techniques. The use of chips with eight chambers and suction for cell immobilisation together with the robotisation of the system makes APC a rapid and simple technique able to perform high-throughput analysis of VGSC blockers such as TTX and to be implemented in food safety monitoring and research programs.

Author Contributions

Conceptualisation, M.C. and F.X.S.; methodology, M.C. and F.X.S.; investigation, J.R., À.T., M.A. and F.X.S.; writing—original draft preparation, M.C., J.R., À.T., M.A. and F.X.S.; writing—review and editing, M.C., J.R., À.T., M.A., J.D. and F.X.S.; project administration, M.C.; funding acquisition, M.C. and F.X.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministerio de Ciencia e Innovación (MICIN) and the Agencia Estatal de Investigación (AEI) (Spain) through the CELLECTRA (PID2020-112976RB-C21 and PID2020-112976RB-C22) project. J.R. acknowledges IRTA for his Ph.D. grant (CPI0422). A.T. acknowledges Ministerio de Universidades (Spain) for her Margarita Salas postdoc grant (2021URV-MS-24). M.A. acknowledges MICIN and AEI for her Ph.D. grant (PRE2019-088181). Authors also acknowledge the support from the CERCA Program/Generalitat de Catalunya. The article processing fees were funded by MDPI.

Data Availability Statement

Data availability upon request.

Acknowledgments

This work would not have been possible without the intervention of Marisa Vinyals from Almirall, S.A. The authors want to thank Almirall, S.A. for the kind transfer of use of the automated patch clamp equipment. The authors would also like to express their gratitude to Alison Obergrussberger and her team from Nanion Technologies GmbH for their technical assistance.

Conflicts of Interest

The authors declare no conflicts of interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the manuscript writing; or in the decision to publish the results.

References

  1. Magarlamov, T.Y.; Melnikova, D.I.; Chernyshev, A.V. Tetrodotoxin-producing bacteria: Detection, distribution and migration of the toxin in aquatic systems. Toxins 2017, 9, 116. [Google Scholar] [CrossRef] [PubMed]
  2. Turner, A.D.; Fenwick, D.; Powell, A.; Dhanji-Rapkova, M.; Ford, C.; Hatfield, R.G.; Santos, A.; Martinez-Urtaza, J.; Bean, T.P.; Baker-Austin, C.; et al. New invasive nemertean species (Cephalothrix simula) in England with high levels of tetrodotoxin and a microbiome linked to toxin metabolism. Mar. Drugs 2018, 16, 452. [Google Scholar] [CrossRef] [PubMed]
  3. Chau, R.; Kalaitzis, J.A.; Neilan, B.A. On the origins and biosynthesis of tetrodotoxin. Aquat. Toxicol. 2011, 104, 61–72. [Google Scholar] [CrossRef] [PubMed]
  4. Hanifin, C.T. The chemical and evolutionary ecology of tetrodotoxin (TTX) toxicity in terrestrial vertebrates. Mar. Drugs 2010, 8, 577–593. [Google Scholar] [CrossRef]
  5. Thuesen, E.V.; Kogure, K.; Hashimoto, K.; Nemoto, T. Poison arrowworms: A tetrodotoxin venom in the marine phylum Chaetognatha. J. Exp. Mar. Bio. Ecol. 1998, 116, 249–256. [Google Scholar] [CrossRef]
  6. Hwang, P.A.; Tsai, Y.H.; Lin, S.J.; Hwang, D.F. The gastropods possessing TTX and/or PSP. Food Rev. Int. 2007, 23, 321–340. [Google Scholar] [CrossRef]
  7. Bane, V.; Lehane, M.; Dikshit, M.; O’Riordan, A.; Furey, A. Tetrodotoxin: Chemistry, toxicity, source, distribution and detection. Toxins 2014, 6, 693–775. [Google Scholar] [CrossRef] [PubMed]
  8. Gummin, D.D.; Mowry, J.B.; Beuhler, M.C.; Spyker, D.A.; Bronstein, A.C.; Rivers, L.J.; Pham, N.P.T.; Weber, J. 2020 Annual report of the American association of poison control center’s national poison data system (NPDS): 38th annual report. Clin. Toxicol. 2021, 59, 1282–1501. [Google Scholar] [CrossRef] [PubMed]
  9. Rodríguez, P.; Alfonso, A.; Vale, C.; Alfonso, C.; Vale, P.; Tellez, A.; Botana, L.M. First toxicity report of tetrodotoxin and 5,6,11-trideoxyTTX in the trumpet shell Charonia lampas lampas in Europe. Anal. Chem. 2008, 80, 5622–5629. [Google Scholar] [CrossRef]
  10. Fernández-Ortega, J.F.; Morales-de los Santos, J.M.; Herrera-Gutiérrez, M.E.; Fernández-Sanchez, V.; Rodrígez Loureo, P.; Alfonso Rancaño, A.; Téllez-Andrade, A. Seafood intoxication by tetrodotoxin: First case in Europe. J. Emerg. Med. 2010, 39, 612–617. [Google Scholar] [CrossRef]
  11. Ulman, A.; Yildiz, T.; Demirel, N.; Canak, O.; Yemişken, E.; Pauly, D. The biology and ecology of the invasive silver-cheeked toadfish (Lagocephalus sceleratus), with emphasis on the Eastern Mediterranean. NeoBiota 2021, 68, 145–175. [Google Scholar] [CrossRef]
  12. Katikou, P.; Gokbulut, C.; Kosker, A.R.; Campàs, M.; Ozogul, F. An updated review of tetrodotoxin and its peculiarities. Mar. Drugs 2022, 20, 47. [Google Scholar] [CrossRef] [PubMed]
  13. Filiz, H.; Er, M. Akdeniz’in yeni misafiri [New guests in the Mediterranean Sea]. Deniz Magazin Dergisi 2004, 3, 52–54. [Google Scholar]
  14. Akyol, O.; Ünal, V.; Ceyhan, T.; Bilecenoglu, M. First confirmed record of Lagocephalus sceleratus (Gmelin, 1789) in the Mediterranean Sea. J. Fish Biol. 2005, 66, 1183–1186. [Google Scholar] [CrossRef]
  15. Noguchi, T.; Ebesu, J.S.M. Puffer poisoning: Epidemiology and treatment. J. Toxicol. Toxin. Rev. 2001, 20, 1–10. [Google Scholar] [CrossRef]
  16. Regulation (EC) No 854/2004 of the European Parliament and of the Council of 29 April 2004. Laying Down Specific Rules for the Organisation of Official Controls on Products of Animal Origin Intended for Human Consumption. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32004R0854 (accessed on 29 November 2023).
  17. EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain); Knutsen, H.K.; Alexander, J.; Barregård, L.; Bignami, M.; Brüschweiler, B.; Ceccatelli, S.; Cottrill, B.; Dinovi, M.; Edler, L.; et al. Scientific opinion on the risks for public health related to the presence of tetrodotoxin (TTX) and TTX analogues in marine bivalves and gastropods. J. EFSA 2017, 15, 4752. [Google Scholar]
  18. Quilliam, M.A.; Thomson, B.A.; Scott, G.J.; Siu, K.M. Ion-spray mass spectrometry of marine neurotoxins. Rapid Commun. Mass Spectrom. 1989, 3, 145–150. [Google Scholar] [CrossRef]
  19. Manger, R.L.; Leja, L.S.; Lee, S.Y.; Hungerford, J.M.; Wekell, M.M. Tetrazolium-based cell bioassay for neurotoxins active on voltage-sensitive sodium channels: Semiautomated assay for saxitoxins, brevetoxins, and ciguatoxins. Anal. Biochem. 1993, 214, 190–194. [Google Scholar] [CrossRef]
  20. Reverté, L.; Soliño, L.; Carnicer, O.; Diogène, J.; Campàs, M. Alternative methods for the detection of emerging marine toxins: Biosensors, biochemical assays and cell-based assays. Mar. Drugs 2014, 12, 5719–5763. [Google Scholar] [CrossRef]
  21. Cañete, E.; Diogène, J. Comparative study of the use of neuroblastoma cells (Neuro-2a) and neuroblastoma-glioma hybrid cells (NG108-15) for the toxic effect quantification of marine toxins. Toxicon 2008, 52, 541–550. [Google Scholar] [CrossRef]
  22. Alkassar, M.; Leonardo, S.; Diogène, J.; Campàs, M. Immobilisation of Neuro-2a cells on electrodes and electrochemical detection of MTT formazan crystals to assess their viability. Bioelectrochemistry 2022, 148, 108274. [Google Scholar] [CrossRef] [PubMed]
  23. Reverté, J.; Alkassar, M.; Diogène, J.; Campàs, M. Detection of ciguatoxins and tetrodotoxins with biosensors and other smart bioanalytical systems. Foods 2023, 12, 2043. [Google Scholar] [CrossRef] [PubMed]
  24. Kogure, K.; Tampline, M.; Simidu, U.; Colwell, R.R. A tissue culture assay for tetrodotoxin, saxitoxin and related toxins. Toxicon 1988, 26, 191–197. [Google Scholar] [CrossRef] [PubMed]
  25. Alkassar, M.; Sanchez-Henao, A.; Reverté, J.; Barreiro, L.; Rambla-Alegre, M.; Leonardo, S.; Mandalakis, M.; Peristeraki, P.; Diogène, J.; Campàs, M. Evaluation of toxicity equivalency factors of tetrodotoxin analogues with a Neuro-2a cell-based assay and application to puffer fish from Greece. Mar. Drugs 2023, 21, 432. [Google Scholar] [CrossRef] [PubMed]
  26. Shao, B.Y.; Chen, B.; Chen, W.B.; Yang, F.; Miao, T.Y.; Peng, J. Preparation and application of tetrodotoxin DNA aptamer. Food Sci. 2014, 35, 205–208. [Google Scholar]
  27. Reverté, L.; Rambla-Alegre, M.; Leonardo, S.; Bellés, C.; Campbell, K.; Elliott, C.T.; Gerssen, A.; Klijnstra, M.D.; Diogène, J.; Campàs, M. Development and validation of a maleimide-based enzyme-linked immunosorbent assay for the detection of tetrodotoxin in oysters and mussels. Talanta 2018, 176, 659–666. [Google Scholar] [CrossRef] [PubMed]
  28. Zhao, L.; Huang, Y.; Dong, Y.; Han, X.; Wang, S.; Liang, X. Aptamers and aptasensors for highly specific recognition and sensitive detection of marine biotoxins: Recent advances and perspectives. Toxins 2018, 10, 427. [Google Scholar] [CrossRef] [PubMed]
  29. Campàs, M.; Reverté, J.; Rambla-Alegre, M.; Campbell, K.; Gerssen, A.; Diogène, J. A fast magnetic bead-based colorimetric immunoassay for the detection of tetrodotoxins in shellfish. Food Chem. Toxicol. 2020, 140, 111315. [Google Scholar] [CrossRef] [PubMed]
  30. Shkembi, X.; Skouridou, V.; Svobodova, M.; Leonardo, S.; Bashammakh, A.S.; Alyoubi, A.O.; Campàs, M.; O’Sullivan, C.K. Hybrid antibody-aptamer assay for detection of tetrodotoxin in pufferfish. Anal. Chem. 2022, 93, 14810–14819. [Google Scholar] [CrossRef]
  31. Mattei, C.; Legros, C. The voltage-gated sodium channel: A major target of marine neurotoxins. Toxicon 2014, 91, 84–95. [Google Scholar] [CrossRef]
  32. Ferreiro, S.F.; Vilariño, N.; Carrera, C.; Louzao, M.C.; Cantalapiedra, A.G.; Santamarina, G.; Cifuentes, J.M.; Vieira, A.C.; Botana, L.M. Subacute cardiovascular toxicity of the marine phycotoxin Azaspiracid-1 in rats. Toxicol 2016, 151, 104–114. [Google Scholar] [CrossRef] [PubMed]
  33. Inserra, M.; Israel, M.; Caldwell, A.; Castro, J.; Deuis, J.R.; Harrington, A.M.; Keramidas, A.; Garcia-Caraballo, S.; Maddern, J.; Erickson, A.; et al. Multiple sodium channel isoforms mediate the pathological effects of Pacific ciguatoxin-1. Sci. Rep. 2017, 7, 42810. [Google Scholar] [CrossRef]
  34. Finol-Urdaneta, R.K.; Zhorov, B.S.; Baden, D.G.; Adams, D.J. Brevetoxin versus brevenal modulation of human Nav1 channels. Mar. Drugs 2023, 21, 396. [Google Scholar] [CrossRef] [PubMed]
  35. Alonso, E.; Alfonso, A.; Vieytes, M.R.; Botana, L.M. Evaluation of toxicity equivalent factors of paralytic shellfish poisoning toxins in seven human sodium channels types by an automated high throughput electrophysiology system. Arch. Toxicol. 2016, 90, 479–488. [Google Scholar] [CrossRef] [PubMed]
  36. Randall, A.; McNaughton, N.; Green, P. Properties of voltage-gated Na+ channels in the human rhabdomyosarcoma cell-line SJ-RH30: Conventional and automated patch clamp analysis. Pharmacol. Res. 2006, 54, 118–128. [Google Scholar] [CrossRef] [PubMed]
  37. Rambla-Alegre, M.; Reverté, L.; del Río, V.; de la Iglesia, P.; Palacios, O.; Flores, C.; Caixach, J.; Campbell, K.; Elliott, C.T.; Izquierdo-Muñoz, A.; et al. Evaluation of tetrodotoxins in puffer fish caught along the Mediterranean coast of Spain. Toxin profile of Lagocephalus sceleratus. Environ. Res. 2017, 158, 1–6. [Google Scholar] [CrossRef] [PubMed]
  38. Horwitz, W.; Albert, R. The Horwitz ratio (HorRat): A useful index of method performance with respect to precision. J. AOAC Int. 2006, 89, 1095–1109. [Google Scholar] [CrossRef] [PubMed]
  39. AOAC International. Guidelines for Standard Method Performance Requirements. In AOAC Official Methods of Analysis; AOAC International: Rockville, Maryland, 2016; Appendix F; pp. 1–18. [Google Scholar]
  40. Reverté, L.; Campbell, K.; Rambla-Alegre, M.; Elliott, C.T.; Diogène, J.; Campàs, M. Immunosensor array platforms based on self-assembled dithiols for the electrochemical detection of tetrodotoxins in puffer fish. Anal. Chim. Acta 2017, 989, 95–103. [Google Scholar] [CrossRef] [PubMed]
  41. Toh, M.F.; Brooks, J.M.; Strassmaier, T.; Haedo, R.J.; Puryear, C.B.; Roth, B.L.; Ouk, K.; Pin, S.S. Application of high-throughput automated patch-clamp electrophysiology to study voltage-gated ion channel function in primary cortical cultures. SLAS Discov. 2020, 25, 447–457. [Google Scholar] [CrossRef]
  42. Ritzau-Jost, A.; Nerlich, J.; Kaas, T.; Krueger, M.; Tsintsadze, T.; Eilers, J.; Barbour, B.; Smith, S.M.; Hallermann, S. Direct whole-cell patch-clamp recordings from small boutons in rodent primary neocortical neuron cultures. Cell Rep. 2023, 4, 102168. [Google Scholar] [CrossRef]
  43. Masters, J. Human cancer cell lines: Fact and fantasy. Nat. Rev. Mol. Cell Biol. 2000, 1, 233–236. [Google Scholar] [CrossRef]
  44. Noreng, S.; Li, T.; Payandeh, J. Structural Pharmacology of voltage-gated sodium channels. J. Mol. Biol. 2021, 433, 166967. [Google Scholar] [CrossRef] [PubMed]
  45. Tsukamoto, T.; Chiba, Y.; Wakamori, M.; Yamada, T.; Tsunogae, S.; Cho, Y.; Sakakibara, R.; Imazu, T.; Tokoro, S.; Satake, Y.; et al. Differential binding of tetrodotoxin and its derivatives to voltage-sensitive sodium channel subtypes (Nav 1.1 to Nav 1.7). Br. J. Pharmacol. 2017, 174, 3881–3892. [Google Scholar] [CrossRef] [PubMed]
  46. Clare, J.J.; Tate, S.N.; Nobbs, M.; Romanos, M.A. Voltage-gated sodium channels as therapeutic targets. Drug Discov. Today 2000, 5, 506–520. [Google Scholar] [CrossRef] [PubMed]
  47. Denomme, N.; Lukowski, A.L.; Hull, J.M.; Jameson, M.B.; Bouza, A.A.; Narayan, A.R.H.; Isom, L.L. The voltage-gated sodium channel inhibitor, 4,9-anhydrotetrodotoxin, blocks human Nav1.1 in addition to Nav1.6. Neurosci. Lett. 2020, 724, 134853. [Google Scholar] [CrossRef] [PubMed]
  48. Leung, Y.M.; Huang, C.F.; Chao, C.C.; Lu, D.Y.; Kuo, C.S.; Cheng, T.H.; Chang, L.Y.; Chou, C.H. Voltage-gated K+ channels play a role in cAMP-stimulated neuritogenesis in mouse neuroblastoma N2A cells. J. Cell Physiol. 2011, 226, 1090–1098. [Google Scholar] [CrossRef] [PubMed]
  49. Khan, F.; Saify, Z.S.; Jamali, K.S.; Naz, S.; Hassan, S.; Siddiqui, S. Vitex negundo induces an anticonvulsant effect by inhibiting voltage gated sodium channels in murine Neuro 2A cell line. Pak. J. Pharm. Sci. 2018, 31, 297–303. [Google Scholar] [PubMed]
  50. Badisa, R.B.; Wi, S.; Jones, Z.; Mazzio, E.; Zhou, Y.; Rosenberg, J.T.; Latinwo, L.M.; Grant, S.C.; Goodman, C.B. Cellular and molecular responses to acute cocaine treatment in neuronal-like N2a cells: Potential mechanism for its resistance in cell death. Cell Death Discov. 2018, 4, 13. [Google Scholar] [CrossRef] [PubMed]
  51. Wu, P.-M.; Cho, H.-Y.; Chiang, C.-W.; Chuang, T.-H.; Wu, S.-N.; Tu, Y.-F. Characterization in inhibitory effectiveness of carbamazepine in voltage-gated Na+ and erg-mediated K+ currents in a mouse neural crest-derived (Neuro-2a) cell line. Int. J. Mol. Sci. 2022, 23, 7892. [Google Scholar] [CrossRef]
  52. Wu, P.-M.; Lai, P.-C.; Cho, H.-Y.; Chuang, T.-H.; Wu, S.-N.; Tu, Y.-F. Effective perturbations by phenobarbital on INa, IK(erg), IK(M) and IK(DR) during pulse train stimulation in neuroblastoma Neuro-2a cells. Biomedicines 2022, 10, 1968. [Google Scholar] [CrossRef]
  53. LePage, K.T.; Dickey, R.W.; Gerwick, W.H.; Jester, E.L.; Murray, T.F. On the use of Neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies. Crit. Rev. Neurobiol. 2005, 17, 27–50. [Google Scholar] [CrossRef]
  54. Meadows, S.L.; Malhotra, J.; Loukas, A.; Thyagarajan, V.; Kazen-Gillespie, K.A.; Koopman, M.C.; Kriegler, S.; Isom, L.L.; Ragsdale, D.S. Functional and biochemical analysis of a sodium channel β1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J. Neurosci. 2002, 22, 10699–10709. [Google Scholar] [CrossRef] [PubMed]
  55. Reckziegel, G.; Beck, H.; Schramm, J.; Elger, C.E.; Urban, B.W. Electrophysiological characterization of Na+ currents in acutely isolated human hippocampal dentate granule cells. J. Physiol. 1998, 509, 139–150. [Google Scholar] [CrossRef]
  56. Raposo-Garcia, S.; Cao, A.; Costas, C.; Louzao, M.C.; Vilariño, N.; Vale, C.; Botana, L.M. Mouse N2a neuroblastoma assay: Uncertainties and comparison with alternative cell-based assays for ciguatoxin detection. Mar. Drugs 2023, 21, 590. [Google Scholar] [CrossRef] [PubMed]
  57. Chevrier, P.; Vijayaragavan, K.; Chahine, M. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br. J. Pharmacol. 2009, 142, 576–584. [Google Scholar] [CrossRef]
  58. Obergrussberger, A.; Brüggemann, A.; Goetze, T.A.; Rapedius, M.; Haarmann, C.; Rinke, I.; Becker, N.; Oka, T.; Ohtsuki, A.; Stengel, T.; et al. Automated patch clamp meets high-throughput screening: 384 cells recorded in parallel on a planar patch clamp module. SLAS Technol. 2016, 21, 779–793. [Google Scholar] [CrossRef]
  59. John, V.H.; Main, M.J.; Powell, A.J.; Gladwell, Z.M.; Hick, C.; Sidhu, H.S.; Clare, J.J.; Tate, S.; Trezise, D.J. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology 2004, 46, 425–438. [Google Scholar] [CrossRef] [PubMed]
  60. Terlau, H.; Heinemann, S.H.; Stuhmer, W.; Pusch, M.; Conti, F.; Imoto, K.; Numa, S. Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett. 1991, 293, 93–96. [Google Scholar] [CrossRef]
  61. Chahine, M.; Bennett, P.B.; George, A.L., Jr.; Horn, R. Functional modulation of human brain Nav1.3 sodium channels, expressed in mammalian cells, by auxiliary beta1, beta2 and beta3 subunits. Pflügers Arch.-Eur. J. Appl. Physiol. 1994, 427, 136–142. [Google Scholar] [CrossRef]
  62. Smith, M.R.; Smith, R.D.; Plummer, N.W.; Meisler, M.H.; Goldin, A.L. Functional analysis of the mouse Scn8a sodium channel. J. Neurosci. 1998, 18, 6093–6102. [Google Scholar] [CrossRef]
  63. Klugbauer, N.; Lacinova, L.; Flockerzi, V.; Hofmann, F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J. 1995, 14, 1084–1090. [Google Scholar] [CrossRef] [PubMed]
  64. El-Sayed, M.; Yacout, G.A.; El-Samra, M.; Ali, A.; Kotb, S.M. Toxicity of the Red Sea pufferfish Pleuranacanthus sceleratus ‘El-Karad’. Ecotoxicol. Environ. Saf. 2003, 56, 367–372. [Google Scholar] [CrossRef] [PubMed]
  65. Kosker, A.R.; Özogul, F.; Durmus, M.; Ucar, Y.; Ayas, D.; Regenstein, J.M.; Özogul, Y. Tetrodotoxin levels in pufferfish (Lagocephalus sceleratus) caught in the Northeastern Mediterranean Sea. Food Chem. 2016, 210, 332–337. [Google Scholar] [CrossRef] [PubMed]
  66. Christidis, G.; Mandalakis, M.; Anastasiou, T.I.; Tserpes, G.; Peristeraki, P.; Somarakis, S. Keeping Lagocephalus sceleratus off the table: Sources of variation in the quantity of TTX, TTX analogues, and risk of tetrodotoxication. Toxins 2021, 13, 896. [Google Scholar] [CrossRef] [PubMed]
  67. Kosker, A.R.; Karakus, M.; Katikou, P.; Dal, I.; Durmus, M.; Ucar, Y.; Ayas, D.; Özogul, F. Monthly variation of tetrodotoxin levels in pufferfish (Lagocephalus sceleratus) caught from Antalya Bay, Mediterranean Sea. Mar. Drugs 2023, 21, 527. [Google Scholar] [CrossRef]
  68. Anastasiou, T.I.; Kagiampaki, E.; Kondylatos, G.; Tselepides, A.; Peristeraki, P.; Mandalakis, M. Assessing the toxicity of Lagocephalus sceleratus pufferfish from the Southeastern Aegean Sea and the relationship of tetrodotoxin with gonadal hormones. Mar. Drugs 2023, 21, 520. [Google Scholar] [CrossRef] [PubMed]
  69. Matsumoto, T.; Nagashima, Y.; Kusuhara, H.; Ishizaki, S.; Shimakura, K.; Shiomi, K. Evaluation of hepatic uptake clearance of tetrodotoxin in the puffer fish Takifugu rubripes. Toxicon 2008, 52, 369–374. [Google Scholar] [CrossRef] [PubMed]
  70. Ikeda, K.; Murakami, Y.; Emoto, Y.; Ngy, L.; Taniyama, S.; Yagi, M.; Takatani, T.; Arakawa, O. Transfer profile of intramuscularly administered tetrodotoxin to non-toxic cultured specimens of the pufferfish Takifugu rubripes. Toxicon 2009, 53, 99–103. [Google Scholar] [CrossRef] [PubMed]
  71. Wang, J.; Araki, T.; Tatsuno, R.; Nina, S.; Ikeda, K.; Takatani, T.; Arakawa, O. Transfer profile of orally and intramuscularly administered tetrodotoxin to artificial hybrid specimens of the pufferfish Takifugu rubripes and Takifugu porphyreus. J. Food Hyg. Soc. Jpn. 2012, 53, 33–38. [Google Scholar] [CrossRef]
  72. Akbora, H.D.; Kunter, I.; Erçetïn, T.; Elagöz, A.M.; Çïçek, B.A. Determination of tetrodotoxin (TTX) levels in various tissues of the silver cheeked puffer fish (Lagocephalus sceleratus (Gmelin, 1789)) in Northern Cyprus Sea (Eastern Mediterranean). Toxicon 2020, 175, 1–6. [Google Scholar] [CrossRef]
  73. Nakamura, M.; Yasumoto, T. Tetrodotoxin derivatives in puffer fish. Toxicon 1985, 23, 271–276. [Google Scholar] [CrossRef]
  74. Satake, Y.; Adachi, M.; Tokoro, S.; Yotsu-Yamashita, M.; Isobe, M.; Nishikawa, T. Synthesis of 5- and 8-deoxytetrodotoxin. Chem. Asian J. 2014, 9, 1922–1932. [Google Scholar] [CrossRef]
  75. Leonardo, S.; Rambla-Alegre, M.; Samdal, I.A.; Miles, C.O.; Kilcoyne, J.; Diogène, J.; O’Sullivan, C.K.; Campàs, M. Immunorecognition magnetic supports for the development of an electrochemical immunoassay for azaspiracid detection in mussels. Biosens. Bioelectron. 2017, 92, 200–206. [Google Scholar] [CrossRef]
  76. Reverté, L.; de la Iglesia, P.; del Río, V.; Campbell, K.; Elliott, C.T.; Kawatsu, K.; Katikou, P.; Diogène, J.; Campàs, M. Detection of tetrodotoxins in puffer fish by a self-assembled monolayer-based immunoassay and comparison with surface plasmon resonance, LC-MS/MS, and mouse bioassay. Anal. Chem. 2015, 87, 10839–10847. [Google Scholar] [CrossRef]
Marinedrugs 22 00176 g001
Figure 1. Intensity of Nav currents in Neuro-2a cells at different applied membrane potentials prior to the exposure to VGSC blockers (n = 4).
Figure 1. Intensity of Nav currents in Neuro-2a cells at different applied membrane potentials prior to the exposure to VGSC blockers (n = 4).
Marinedrugs 22 00176 g001
Marinedrugs 22 00176 g002
Figure 2. Dose–response curves for lidocaine and tetracaine showing the blocking effect of these compounds on Nav currents in Neuro-2a cells (n = 4).
Figure 2. Dose–response curves for lidocaine and tetracaine showing the blocking effect of these compounds on Nav currents in Neuro-2a cells (n = 4).
Marinedrugs 22 00176 g002
Marinedrugs 22 00176 g003
Figure 3. Dose–response curve for TTX showing the blocking effect of this toxin on Nav currents in Neuro-2a cells (n = 4). Inset: traces from APC recordings at different TTX concentrations.
Figure 3. Dose–response curve for TTX showing the blocking effect of this toxin on Nav currents in Neuro-2a cells (n = 4). Inset: traces from APC recordings at different TTX concentrations.
Marinedrugs 22 00176 g003
Marinedrugs 22 00176 g004
Figure 4. Effect of different dilutions of different pufferfish tissue extracts from a S. pachygaster specimen (TTX-free) on Nav currents in Neuro-2a cells (n = 4).
Figure 4. Effect of different dilutions of different pufferfish tissue extracts from a S. pachygaster specimen (TTX-free) on Nav currents in Neuro-2a cells (n = 4).
Marinedrugs 22 00176 g004
Marinedrugs 22 00176 g005
Figure 5. Dose–response curves for TTX in the absence and presence of different pufferfish tissue extracts from a S. pachygaster specimen (TTX-free) at 1:20 dilution (n = 4).
Figure 5. Dose–response curves for TTX in the absence and presence of different pufferfish tissue extracts from a S. pachygaster specimen (TTX-free) at 1:20 dilution (n = 4).
Marinedrugs 22 00176 g005
Table 1. Hill slope and IC50 values obtained from the sigmoidal four-parameter logistic equations for TTX in the absence and presence of different pufferfish tissue extracts from a S. pachygaster specimen (TTX-free) at 1:20 dilution (n = 4).
Table 1. Hill slope and IC50 values obtained from the sigmoidal four-parameter logistic equations for TTX in the absence and presence of different pufferfish tissue extracts from a S. pachygaster specimen (TTX-free) at 1:20 dilution (n = 4).
TissueHill SlopeIC50 Value (nM)R2
Muscle0.997 ± 0.0684.927 ± 2.3500.9950
Skin0.910 ± 0.1205.017 ± 1.5870.9961
Liver1.167 ± 0.2045.118 ± 0.9950.9886
Gonads0.801 ± 0.1494.264 ± 0.6680.9859
No tissue1.089 ± 0.0976.380 ± 0.8600.9912
Table 2. TTX equivalent contents (mg TTX equiv./kg of tissue) in L. sceleratus by several techniques, including APC (n = 4) and CBA (n = 3) from this work.
Table 2. TTX equivalent contents (mg TTX equiv./kg of tissue) in L. sceleratus by several techniques, including APC (n = 4) and CBA (n = 3) from this work.
TechniqueMuscleSkinLiverGonadsReference
APC1.593.3213.8022.46This work
CBA2.783.6818.5326.63This work
LC-MS/MS *1.432.023.9634.62[37]
LC-HRMS *1.232.427.6739.44[37]
mELISA2.533.5028.3033.55[37]
Electrochemical immunosensor1.452.1116.6733.90[40]
Optical SPR immunosensor3.514.4224.8230.50[40]
* TTX equiv. contents after the application of TEFs to the different TTX analogues [25].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Campàs, M.; Reverté, J.; Tudó, À.; Alkassar, M.; Diogène, J.; Sureda, F.X. Automated Patch Clamp for the Detection of Tetrodotoxin in Pufferfish Samples. Mar. Drugs 2024, 22, 176. https://doi.org/10.3390/md22040176

AMA Style

Campàs M, Reverté J, Tudó À, Alkassar M, Diogène J, Sureda FX. Automated Patch Clamp for the Detection of Tetrodotoxin in Pufferfish Samples. Marine Drugs. 2024; 22(4):176. https://doi.org/10.3390/md22040176

Chicago/Turabian Style

Campàs, Mònica, Jaume Reverté, Àngels Tudó, Mounira Alkassar, Jorge Diogène, and Francesc X. Sureda. 2024. "Automated Patch Clamp for the Detection of Tetrodotoxin in Pufferfish Samples" Marine Drugs 22, no. 4: 176. https://doi.org/10.3390/md22040176

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop